miR-29b inhibited MMP-2 expression, leading to an attenuation of the invasive capacity of HCC cells in vitro [73], while in glioma cell lines and tumors, miR-205 was found to inhibit invasion by targeting VEGF-A [78,82]. Here, VEGFA is linked to glioma.